Jeffrey Arvin Fink insider trades
Open-market stock purchases and sales by Jeffrey Arvin Fink, Director at Lipocine Inc, from SEC Form 4 filings since Jan 6, 2014.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- LPCN Lipocine Inc: 1 sale, last Jun 4, 2025